Exome Asset Management’s TG Therapeutics TGTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-207,627	Closed	-$4.86M	–	79
2024 Q3	$4.86M	Sell	207,627 -43,973	-17%	-$1.03M	3.28%	5
2024 Q2	$4.48M	Buy	251,600 +21,300	+9%	+$379K	3.99%	4
2024 Q1	$3.5M	Buy	230,300 +27,000	+13%	+$411K	3%	6
2023 Q4	$3.47M	Buy	+203,300	New	+$3.47M	3.43%	6